Table 1.
Participant Characteristics
| Characteristics | N=202 |
|---|---|
| Age | 72.0 ± 7.5 |
| Women | 109 (54%) |
| Non-white | 105 (52%) |
| BMI (kg/m2) | 33.2 ± 8.8 |
| Ejection fraction < 45% | 106 (52%) |
| Days Hospitalized at Index Hospitalization, median (IQR) | 5 (3,7) |
| Patients with previous hospitalizations within 6 months | 89 (44%) |
| Patients with previous HF hospitalizations within 6 months | 55 (27%) |
| BNP (n=117) | 923 ± 958 |
| Pro-BNP (n=77) | 5968 ± 10066 |
| Comorbidities | |
| Diabetes mellitus | 111 (55%) |
| Hypertension | 187 (93%) |
| Hyperlipidemia | 140 (69%) |
| Chronic obstructive pulmonary disease | 65 (32%) |
| Chronic kidney disease | 67 (33%) |
| History of Stroke | 32 (16%) |
| Arthritis | 94 (47%) |
| History of Cancer | 42 (21%) |
| History of Depression | 33 (16%) |
| Physical Function | |
| SPPB total score | 6.0 ± 2.5 |
| 6-minute walk distance (m) | 185 ± 99 |
| Gait speed (m/s) | 0.61 ± 0.21 |
| Cognitive Function (MoCA Score) | 21.7±4.5 |
| Quality of Life Measures | |
| KCCQ Overall Score | 41 ± 21 |
| KCCQ Physical Limitation Score | 47 ± 24 |
| KCCQ Total Symptom Score | 33 ± 22 |
| KCCQ Quality of Life Score | 39 ± 25 |
| KCCQ Social Limitation Score | 42 ± 31 |
| SF-12 PCS | 28 ± 9 |
| SF-12 MCS | 44 ± 14 |
| EuroQol 5D-5L Components | |
| Walking | 2.5 ± 1.0 |
| Self-Care | 1.7 ± 0.9 |
| Usual Activities | 2.7 ± 1.2 |
| Pain/Discomfort | 2.4 ± 1.1 |
| Depression/Anxiety | 1.8 ± 1.0 |
| Visual Analog Scale (0–100) | 57 ± 23 |
Values presented as mean ± standard deviation or N (%) unless otherwise noted. Abbreviations: BMI – body mass index; BNP – B-type natriuretic peptide; Pro-BNP – n-terminal brain natriuretic peptide; SPPB – Short Physical Performance Battery; MoCA – Montreal Cognitive Assessment; KCCQ – Kansas City Cardiomyopathy Questionnaire; SF-12 – Short Form 12; PCS – Physical Composite Score; MCS – Mental Composite Score.